Remission of infantile generalized myofibromatosis after interferon alpha therapy

J Pediatr Hematol Oncol. 2008 Feb;30(2):179-81. doi: 10.1097/MPH.0b013e31815e62bb.

Abstract

Infantile myofibromatosis is the most common fibrous tumor of infancy. Solitary or generalized myofibromas without visceral involvement usually regress within a few months. The multifocal disease infantile generalized myofibromatosis, with visceral involvement, is associated with a significant mortality due to the effect of tumors on vital organs. We report a case of infantile generalized myofibromatosis with visceral involvement, including 2 right atrium tumors. The infant expressed high circulating vascular endothelial growth factor and fibroblast growth factor-2 levels, and interferon alpha-2b was started as antiangiogenic treatment, aimed at triggering regression of the life-threatening cardiac lesions. The tumors regressed and vascular endothelial growth factor and fibroblast growth factor-2 levels were reduced after treatment discontinuation.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Fibroblast Growth Factor 2 / blood
  • Fibroblast Growth Factor 2 / urine
  • Humans
  • Infant
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Myofibromatosis / drug therapy*
  • Recombinant Proteins
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor A / urine

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Vascular Endothelial Growth Factor A
  • Fibroblast Growth Factor 2